Ranked #8,666 of 8,699 institutional investors
Caxton Corp
Princeton, NJ
$2.7M
US stock portfolio at live prices · today −$46K (−1.70%)
Market closed. Prices as of Nov 20, 5:41 AM ET
- Value at quarter end (Q3 2026)
- $2.8M
- Change from Q2 2026
- +$930K (+50.20%)
- Positions
- 12 · 2 new, 0 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$486K of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSPCX 19.1%BRK-B 17.9%TSLA 11.6%VOO 9.27%GOOGL 7.81%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SPCX Space Exploration Technologies Corp. | 3,699 | $512K | 19.1% | Added +42% |
| BRK-B Berkshire Hathaway Inc. | 839 | $480K | 17.9% | Added +11% |
| TSLA Tesla, Inc. | 829 | $310K | 11.6% | New |
| VOO Vanguard S&P 500 ETF | 378 | $249K | 9.27% | Added +12% |
| GOOGL Alphabet Inc. | 769 | $210K | 7.81% | Added +11% |
| BX Blackstone Inc. | 1,780 | $206K | 7.69% | Added +11% |
| KYTX Kyverna Therapeutics, Inc. | 12,347 | $54K | 2.01% | Unchanged |
| LXEO Lexeo Therapeutics, Inc. | 16,962 | $50K | 1.86% | Unchanged |
| XFOR X4 Pharmaceuticals, Inc. | 13,534 | $40K | 1.49% | Reduced −13% |
| IKT Inhibikase Therapeutics, Inc. | 27,775 | $36K | 1.35% | Reduced −2% |
| SABS SAB Biotherapeutics, Inc. | 10,372 | $30K | 1.12% | New |
| ALXO ALX Oncology Holdings Inc. | 20,946 | $21K | 0.80% | Unchanged |